BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16630081)

  • 1. Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?
    Dummer R; Cozzio A; Urosevic M
    Exp Dermatol; 2006 May; 15(5):392-400. PubMed ID: 16630081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in cutaneous lymphomas.
    Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
    J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma.
    Dummer R; Potoczna N; Häffner AC; Zimmermann DR; Gilardi S; Burg G
    Arch Dermatol; 1996 May; 132(5):550-3. PubMed ID: 8624152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous CD4+/CD56+ hematodermic neoplasm.
    Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
    Weaver J; Hsi ED
    J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage?
    Bagot M; Bouloc A; Charue D; Wechsler J; Bensussan A; Boumsell L
    J Invest Dermatol; 1998 Dec; 111(6):1242-4. PubMed ID: 9856854
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cutaneous B-cell lymphoma: classification and treatment.
    Willemze R
    Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immuno-intervention in cutaneous lymphomas].
    Dummer R; Heinzerling L; Schmid MH; Burg G
    Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspective of cutaneous lymphoma reserach].
    Dummer R; Urosevic M; Cozzio A; Asagoe K; Döbbeling U; Burg G
    J Dtsch Dermatol Ges; 2006 Jun; 4(6):492-5. PubMed ID: 16734840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.